-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Silence Therapeutics plc quarterly/annual Depreciation history and growth rate from Q1 2024 to Q1 2025.
- Silence Therapeutics plc Depreciation for the quarter ending March 31, 2025 was $73K, a 17% decline year-over-year.
- Silence Therapeutics plc annual Depreciation for 2024 was $336K, a 8.94% decline from 2023.
- Silence Therapeutics plc annual Depreciation for 2023 was $369K, a 2.64% decline from 2022.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)